Citigroup »

Oncocyte Corporation shares owned by Citigroup

Quarter-by-quarter ownership of Oncocyte Corporation (IMDX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Oncocyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Oncocyte Corporation held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncocyte Corporation by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7k 815 3.28

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Oncocyte Corporation

Broadwood Capital
AWM Investment Company
Pura Vida Investments
Alyeska Investment Group
Vanguard Capital Management
Vanguard Group
Geode Capital Management
FNY Investment Advisers
BlackRock
Vanguard Fiduciary Trust
Family Office Research
Millennium Management
Susquehanna International
Ghisallo Capital Management
Northern Trust

View all funds holding Oncocyte Corporation